NewGenIVF Group Limited reported a net profit of US$9.9 million and net assets of approximately US$25.98 million for the fiscal year ended December 31, 2025. The company's 13% stake in K25.ai is now valued at approximately US$26 million based on an implied valuation of US$200 million following a Series A round, representing an unrealized gain of about US$8.5 million. Total shares outstanding are expected to reach 5.9 million after the issuance of 2.5 million Class A ordinary shares announced on July 27, 2026. NewGenIVF Group Limited is a technology-driven diversified growth company operating in real estate development, digital asset innovation, and reproductive health solutions.
